These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9134631)

  • 1. Clinical features in 36 patients homozygous for the ARG 506-->GLN factor V mutation.
    Emmerich J; Alhenc-Gelas M; Aillaud MF; Juhan-Vague I; Jude B; Garcin JM; Dreyfus M; de Moerloose P; Le Querrec A; Priollet P; Berruyer M; Vallantin X; Wolf M; Aiach M; Fiessinger JN
    Thromb Haemost; 1997 Apr; 77(4):620-3. PubMed ID: 9134631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor V (Arg 506-->Gln) mutation in young survivors of myocardial infarction.
    Ardissino D; Peyvandi F; Merlini PA; Colombi E; Mannucci PM
    Thromb Haemost; 1996 May; 75(5):701-2. PubMed ID: 8725707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V.
    Greengard JS; Eichinger S; Griffin JH; Bauer KA
    N Engl J Med; 1994 Dec; 331(23):1559-62. PubMed ID: 7969326
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The factor V Leiden mutation which predisposes to thrombosis is not common in patients with antiphospholipid syndrome.
    Dizon-Townson D; Hutchison C; Silver R; Branch DW; Ward K
    Thromb Haemost; 1995 Oct; 74(4):1029-31. PubMed ID: 8560406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial and venous thrombosis in two Italian families with the factor V Arg506-->Gln mutation.
    Montaruli B; Voorberg J; Tamponi G; Borchiellini A; Muleo G; Pannocchia A; van Mourik JA; Schinco P
    Eur J Haematol; 1996 Jul; 57(1):96-100. PubMed ID: 8698138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new hereditary cause of portal vein thrombosis: the abnormal resistance to activated protein C by the Arg 506-->Gln mutation of the gene of factor V].
    Levoir D; Aubertin JM; Alhenc-Gelas M; Bloch F; Becheur H; Petite JP
    Gastroenterol Clin Biol; 1995; 19(8-9):729-31. PubMed ID: 8522125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations of genes associated with thromboses in ischemic stroke in patients with primary antiphospholipid syndrome].
    Kalashnikova LA; Dobrynina LA; Patrusheva NL; Kovalenko TF; Patrushev LI; Aleksandrova EN; Berkovskiĭ AL; Sergeeva EV; Nasonov EL
    Ter Arkh; 2005; 77(10):49-53. PubMed ID: 16320685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in hemostasis system in patients with hereditary thrombophilia caused by mutation of blood coagulation factor V ( factor V Leiden)].
    Papaian LP; Kobilianskaia VA; Sheĭdina AM; Baranovskaia SS; Sirotkina OV; Kargin VD; Saltykova NB; Beliazo OE; Golovina OG; Papaian KA; Tarkovskaia LR
    Ter Arkh; 2001; 73(7):47-51. PubMed ID: 11523408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden mutation is associated with enhanced arterial thrombotic tendency in lean but not in obese mice.
    Nagai N; Lijnen HR; Cleuren AC; Rosendaal FR; Van Hoef B; Hoylaerts MF; Van Vlijmen BJ
    Thromb Haemost; 2007 Oct; 98(4):858-63. PubMed ID: 17938812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction].
    Baykan M; Celik S; Uçar F; Kaplan S; Ovali E; Erdöl C
    Anadolu Kardiyol Derg; 2001 Dec; 1(4):242-5; AXIV. PubMed ID: 12101832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V gene A4070G mutation and the risk of cerebral veno-sinus thrombosis occurring during puerperium.
    Dindagur N; Kruthika-Vinod TP; Christopher R
    Thromb Res; 2007; 119(4):497-500. PubMed ID: 16781765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations at the activated protein C cleavage sites Arg336 and Arg562 of factor VIII in Thai patients with venous thrombosis.
    Prayoonwiwat W; Arnutti P; Nathalang O; Suwanasophon C; Viputtigul K
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):880-3. PubMed ID: 12041568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.